HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences (HSCS) has reported Gross Margin for 5 consecutive years, with 58.33% the latest figure, recorded in Q4 2025.

• Quarterly Gross Margin changed N/A year-over-year to 58.33% in Q4 2025, while the trailing twelve-month figure through Apr 2026 was 57.92% (down 827.0% YoY) and the FY2026 annual result came in at 59.06%, up 228.0% from the prior year.
• Gross Margin declined to 58.33% in Q4 2025 per HSCS's latest filing, from 60.0% in the prior quarter.
• Over the last five years, Gross Margin for HSCS reached as high as 69.15% in Q2 2022 and fell as low as 23.09% in Q3 2021.
• A 5-year average of 56.36% and a median of 60.51% in 2025 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2022 — Gross Margin jumped 1329 bps — and 2023, when it slumped 781 bps.
• Year by year, Gross Margin stood at 23.09% in 2021, then jumped by 58 bps to 36.38% in 2022, then soared by 68 bps to 61.03% in 2023, then increased by 13 bps to 68.97% in 2024, then fell by 15 bps to 58.33% in 2025.
• According to Business Quant data, Gross Margin over the past three periods registered 58.33%, 60.0%, and 56.78% for Q4 2025, Q3 2025, and Q2 2025 respectively.